CymaBay Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
CymaBay Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2012 to 2023.
  • CymaBay Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $93.1M, a 279% increase year-over-year.
  • CymaBay Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $346M, a 1308% increase from 2022.
  • CymaBay Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $24.6M, a 79.3% decline from 2021.
  • CymaBay Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $118M, a 128655% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

CymaBay Therapeutics, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $93.1M +$68.5M +279% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q1 2022 $24.5M +$24.5M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $0 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $0 -$108M -100% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 $108M -$30.6M -22.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q1 2018 $139M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q1 2014 $2.4M Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-15

CymaBay Therapeutics, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $346M +$321M +1308% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $24.6M -$93.9M -79.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $118M +$118M +128655% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $92K -$108M -99.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
2019 $108M -$26.9M -19.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 $135M +$35.3M +35.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 $99.7M +$101M Jan 1, 2017 Dec 31, 2017 10-K 2019-02-28
2016 -$986K Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2013 $31.4M +$31.4M Jan 1, 2013 Dec 31, 2013 10-K 2014-03-31
2012 -$12K* Jan 1, 2012 Dec 31, 2012 10-K 2014-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.